This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vaziri, N. D. Articles by Ni, Z. Search for Related Content PubMed PubMed Citation Articles by Vaziri, N. D. Articles by Ni, Z. Related Collections Nutrition Animal models of human disease Hypertension - basic studies Lipid and lipoprotein metabolism Endothelium/vascular type/nitric oxide

(Hypertension. 1999;34:558-562.)
© 1999 American Heart Association, Inc.

Scientific Contributions

Nitric Oxide Synthase Expression in the Course of Lead-Induced Hypertension

Nosratola D. Vaziri; Yaoxian Ding; Zhenmin Ni

From the Division of Nephrology and Hypertension, Department Medicine, University of California, Irvine, Calif.

Correspondence to N.D. Vaziri, MD, Division of Nephrology and Hypertension, Department of Medicine, UCI Medical Center, 101 The City Drive, Orange, CA 92868. E-mail tabotten{at}uci.edu

Abstract—We recently showed elevated reactive oxygen species (ROS), reduced urinary excretion of NO metabolites (NOx), and increased NO sequestration as nitrotyrosine in various tissues in rats with lead-induced hypertension. This study was designed to discern whether the reduction in urinary NOx in lead-induced hypertension is, in part, due to depressed NO synthase (NOS) expression. Male Sprague-Dawley rats were randomly assigned to a lead-treated group (given lead acetate, 100 ppm, in drinking water and regular rat chow), a group given lead and vitamin E–fortified chow, or a normal control group given either regular food and water or vitamin E–fortified food for 12 weeks. Tail blood pressure, urinary NOx excretion, plasma malondialdehyde (MDA), and endothelial and inducible NOS (eNOS and iNOS) isotypes in the aorta and kidney were measured. The lead-treated group exhibited a rise in blood pressure and plasma MDA concentration, a fall in urinary NOx excretion, and a paradoxical rise in vascular and renal tissue eNOS and iNOS expression. Vitamin E supplementation ameliorated hypertension, lowered plasma MDA concentration, and raised urinary NOx excretion while significantly lowering vascular, but not renal, tissue eNOS and iNOS expression. Vitamin E supplementation had no effect on either blood pressure, plasma MDA, or NOS expression in the control group. The study also revealed significant inhibition of NOS enzymatic activity by lead in cell-free preparations. In conclusion, lead-induced hypertension in this model was associated with a compensatory upregulation of renal and vascular eNOS and iNOS expression. This is, in part, due to ROS-mediated NO inactivation, lead-associated inhibition of NOS activity, and perhaps stimulatory actions of increased shear stress associated with hypertension.

Key Words: lead • hypertension, lead-induced • free radicals • nitric oxide • vitamins • antioxidants • lipids

This article has been cited by other articles:

				N. D. Vaziri Mechanisms of lead-induced hypertension and cardiovascular disease Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H454 - H465. [Abstract] [Full Text] [PDF]

				Y. Bravo, Y. Quiroz, A. Ferrebuz, N. D. Vaziri, and B. Rodriguez-Iturbe Mycophenolate mofetil administration reduces renal inflammation, oxidative stress, and arterial pressure in rats with lead-induced hypertension Am J Physiol Renal Physiol, August 1, 2007; 293(2): F616 - F623. [Abstract] [Full Text] [PDF]

				H. V. Robles, E. Romo, A. Sanchez-Mendoza, A. Rios, V. Soto, M. C. Avila-Casado, A. Medina, and B. Escalante Lead exposure effect on angiotensin II renal vasoconstriction Human and Experimental Toxicology, June 1, 2007; 26(6): 499 - 507. [Abstract] [PDF]

				S. Kasperczyk, E. Birkner, A. Kasperczyk, and J. Kasperczyk Lipids, lipid peroxidation and 7-ketocholesterol in workers exposed to lead Human and Experimental Toxicology, June 1, 2005; 24(6): 287 - 295. [Abstract] [PDF]

				H. Negishi, J.-W. Xu, K. Ikeda, M. Njelekela, Y. Nara, and Y. Yamori Black and Green Tea Polyphenols Attenuate Blood Pressure Increases in Stroke-Prone Spontaneously Hypertensive Rats J. Nutr., January 1, 2004; 134(1): 38 - 42. [Abstract] [Full Text] [PDF]

				C. K. Roberts, N. D. Vaziri, R. K. Sindhu, and R. J. Barnard A high-fat, refined-carbohydrate diet affects renal NO synthase protein expression and salt sensitivity J Appl Physiol, March 1, 2003; 94(3): 941 - 946. [Abstract] [Full Text] [PDF]

				L. E. Wold, D. P. Relling, J. Duan, F. L. Norby, and J. Ren Abrogated Leptin-Induced Cardiac Contractile Response in Ventricular Myocytes Under Spontaneous Hypertension: Role of JAK/STAT Pathway Hypertension, January 1, 2002; 39(1): 69 - 74. [Abstract] [Full Text] [PDF]

				N. D. Vaziri, Z. Ni, F. Oveisi, K. Liang, and R. Pandian Enhanced Nitric Oxide Inactivation and Protein Nitration by Reactive Oxygen Species in Renal Insufficiency Hypertension, January 1, 2002; 39(1): 135 - 141. [Abstract] [Full Text] [PDF]

				M. Marques, I. Millas, A. Jimenez, E. Garcia-Colis, J. A. Rodriguez-Feo, S. Velasco, A. Barrientos, S. Casado, and A. Lopez-Farre Alteration of the Soluble Guanylate Cyclase System in the Vascular Wall of Lead-Induced Hypertension in Rats J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2594 - 2600. [Abstract] [Full Text] [PDF]

				E. A. Jaimes, C. Sweeney, and L. Raij Effects of the Reactive Oxygen Species Hydrogen Peroxide and Hypochlorite on Endothelial Nitric Oxide Production Hypertension, October 1, 2001; 38(4): 877 - 883. [Abstract] [Full Text] [PDF]

				G. DENG, N. D. VAZIRI, B. JABBARI, Z. NI, and X.-X. YAN Increased Tyrosine Nitration of the Brain in Chronic Renal Insufficiency: Reversal by Antioxidant Therapy and Angiotensin-Converting Enzyme Inhibition J. Am. Soc. Nephrol., September 1, 2001; 12(9): 1892 - 1899. [Abstract] [Full Text] [PDF]

				N. D. Vaziri, Y. Ding, and Z. Ni Compensatory Up-Regulation of Nitric-Oxide Synthase Isoforms in Lead-Induced Hypertension; Reversal by a Superoxide Dismutase-Mimetic Drug J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 679 - 685. [Abstract] [Full Text] [PDF]

				R. Govers and T. J. Rabelink Cellular regulation of endothelial nitric oxide synthase Am J Physiol Renal Physiol, February 1, 2001; 280(2): F193 - F206. [Abstract] [Full Text] [PDF]

				N. D. Vaziri and Y. Ding Effect of Lead on Nitric Oxide Synthase Expression in Coronary Endothelial Cells : Role of Superoxide Hypertension, February 1, 2001; 37(2): 223 - 226. [Abstract] [Full Text] [PDF]

				N. D. Vaziri, Z. Ni, F. Oveisi, and D. L. Trnavsky-Hobbs Effect of Antioxidant Therapy on Blood Pressure and NO Synthase Expression in Hypertensive Rats Hypertension, December 1, 2000; 36(6): 957 - 964. [Abstract] [Full Text] [PDF]

				C. K. Roberts, N. D. Vaziri, X. Q. Wang, and R. J. Barnard Enhanced NO Inactivation and Hypertension Induced by a High-Fat, Refined-Carbohydrate Diet Hypertension, September 1, 2000; 36(3): 423 - 429. [Abstract] [Full Text] [PDF]

				N. D. Vaziri, X. Q. Wang, F. Oveisi, and B. Rad Induction of Oxidative Stress by Glutathione Depletion Causes Severe Hypertension in Normal Rats Hypertension, July 1, 2000; 36(1): 142 - 146. [Abstract] [Full Text] [PDF]